Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient-centred Benefit-risk Observational Study of Low-dose Aspirin for CVD (Cardiovascular Disease) and CRC (Colorectal Cancer) Prevention

NCT03603366 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03603366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03603366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient-centred Benefit-risk Observational Study of Low-dose Aspirin for CVD (Cardiovascular Disease) and CRC (Colorectal Cancer) Prevention
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
August 14, 2019
Completion date
October 14, 2019
Enrollment
1,028 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, colorectal cancer